[1] Yang W.Epidemiology and trends in diabetes in China[J]. Scientia Sinica Vitae, 2018, 48(8): 812-819.
[2] Çakar M, Balta Ş, Şarlak H, et al.Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients[J]. Archives of Endocrinology and Metabolism, 2015, 59(5): 407-413.
[3] Tonneijck L, Muskiet MHA, Smits MM, et al.Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment[J]. Journal of the American Society of Nephrology, 2017, 28(4): 1023-1039.
[4] Bernardi S, Michelli A, Zuolo G, et al.Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease[J]. Journal of Diabetes Research, 2016, 2016: 1-17.
[5] Hudson BI, Schmidt AM.RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease[J]. Pharmaceutical Research, 2004, 21(7): 1079-1086.
[6] Yan L.Redox imbalance stress in diabetes mellitus: Role of the polyol pathway[J]. Animal Models and Experimental Medicine, 2018, 1(1): 7-13.
[7] Ilatovskaya DV, Levchenko V, Lowing A, et al.Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels[J]. Scientific Reports, 2015, 5(1): 17637.
[8] Hong Q, Zhang L, Das B, et al.Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury[J]. Kidney International, 2018, 93(6): 1330-1343.
[9] Giuliani C.The Flavonoid Quercetin Induces AP-1 Activation in FRTL-5 Thyroid Cells[J]. Antioxidants, 2019, 8(5): 112.
[10] Daenen K, Andries A, Mekahli D, et al.Oxidative stress in chronic kidney disease[J]. Pediatric Nephrology, 2019, 34(6): 975-991.
[11] Halász Z.Endokrin szövődmények primer immundeficientiában[J]. Orvosi Hetilap, 2018, 159(49): 2065-2072.
[12] Muftuoglu M, Mori MP, Souza-Pinto NC de. Formation and repair of oxidative damage in the mitochondrial DNA[J]. Mitochondrion, 2014, 17: 164-181.
[13] Kanwar YS, Sun L, Xie P, et al.A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy[J]. Annual Review of Pathology, 2011, 6(1): 395-423.
[14] Giuliani C.The Flavonoid Quercetin Induces AP-1 Activation in FRTL-5 Thyroid Cells[J]. Antioxidants, 2019, 8(5): 112.
[15] Lim Y.Palmitate reduces starvation-induced ER stress by inhibiting ER-phagy in hypothalamic cells[J]. Mol Brain, 2021, 14(1): 65.
[16] Wang H, Yi X, Guo S, et al.The XBP1-MARCH5-MFN2 Axis Confers ER Stress Resistance by Coordinating Mitochondrial Fission and Mitophagy in Melanoma[J]. J Invest Dermatol, 2021, 141(12): 2932-2943.
[17] Yoo J, Jeong I-K, Ahn KJ, et al.Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy[J]. Metabolism, 2021, 120: 154798.
[18] Lenoir O, Jasiek M, Hénique C, et al.Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis[J]. Autophagy, 2015, 11(7): 1130-1145.
[19] Zhou D, Zhou M, Wang Z, et al.Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions[J]. Journal of Molecular Medicine, 2019, 97(11): 1507-1520.
[20] Zhou D, Zhou M, Wang Z, et al.PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy[J]. Cell Death Disease, 2019, 10(7): 524.
[21] Sun J, Zhu H, Wang X, et al.CoQ10 ameliorates mitochondrial dysfunction in diabetic nephropathy through mitophagy[J]. Journal of Endocrinology, 2019, 240(3): 445-465.
[22] Zhou H, Yue Y, Wang J, et al.Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial complex I-SERCA pathway[J]. Cellular Signalling, 2018, 47: 88-100.
[23] Higgins GC, Coughlan MT.Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?: Disturbed mitophagy in diabetic nephropathy[J]. British Journal of Pharmacology, 2014, 171(8): 1917-1942.
[24] Xiao L.The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1[J]. Redox Biology, 2017, 11: 297-311.
[25] Grumati P, Dikic I, Stolz A. ER-phagy at a glance[J]. Journal of Cell Science, 2018, 131(17): jcs217364.
[26] Song S, Tan J, Miao Y, et al.Crosstalk of autophagy and apoptosis: Involvement of the dual role of autophagy under ER stress[J]. Journal of Cellular Physiology, 2017, 232(11): 2977-2984.
[27] Pandey VK, Mathur A, Kakkar P.Emerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes[J]. Life Sciences, 2019, 216: 246-258.
[28] Sousa GR, Pober D, Galderisi A, et al.Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort-Based Study[J]. Circulation, 2019, 139(6): 730-743.
[29] Sinha SK, Nicholas SB, Sung JH, et al.hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study[J]. Diabetes Care, 2019, 42(11): 2083-2089.
[30] Daniele G, Mendoza RG, Winnier D, et al.The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus[J]. Acta Diabetologica, 2014, 51(1): 123-131.
[31] López-Parra V, Mallavia B, Egido J, et al.Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options[M]. InTech, 2012.
[32] Boels MGS, Koudijs A, Avramut MC, et al.Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy[J]. The American Journal of Pathology, 2017, 187(11): 2430-2440.
[33] Zhang L, Zhao MH, Zuo L, et al.China Kidney Disease Network (CK-NET) 2016 Annual Data Report[J]. Kidney International Supplements, 2020, 10(2): e97-e185. |
